m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT06001
|
[1] | |||
m6A modification
SUV39H1
SUV39H1
FTO
Demethylation
 : m6A sites
Direct
Inhibition
Histone modification
H3K9me3
SUV39H1
LTR12
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | |||
| m6A Target | Histone-lysine N-methyltransferase SUV39H1 (SUV39H1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Histone modification (HistMod) | ||||
| Epigenetic Regulator | Histone-lysine N-methyltransferase SUV39H1 (SUV39H1) | WRITER | View Details | ||
| Regulated Target | Histone H3 lysine 9 trimethylation (H3K9me3) | View Details | |||
| Downstream Gene | LTR12 | View Details | |||
| Crosstalk Relationship | m6A → Histone modification | Inhibition | |||
| Crosstalk Mechanism | m6A modification impacts directly histone modification through modulating the expression level of histone-associated enzymes | ||||
| Crosstalk Summary | FTO deletion and METTL16 overexpression significantly increased m6A levels. This led to the downregulation of the methyltransferase Histone-lysine N-methyltransferase SUV39H1 (SUV39H1), resulting in reduced Histone H3 lysine 9 trimethylation (H3K9me3) expression, which activated LTR7 and LTR12, subsequently activating ERV1. | ||||
| Responsed Disease | Ageing-related disease | ICD-11: 9B10-9B60 | |||
Full List of Potential Compound(s) Related to This m6A-centered Crosstalk
| Histone-lysine N-methyltransferase SUV39H1 (SUV39H1) | 1 Compound(s) Regulating the Target | Click to Show/Hide the Full List | ||
 Compound Name |
chaetocin | Investigative | [2] | |
|---|---|---|---|---|
| Synonyms |
Chetocin; 28097-03-2; Chaetocin from Chaetomium minutum; BRN 5722505; AC1L4PPK; GTPL8388; SCHEMBL13662584; CHEBI:94977; MolPort-003-983-881; NSC745363; NSC-745363; LS-52961; Chaetocin from Chaetomium minutum, > J-016970; BRD-A85860691-001-01-4; BRD-A85860691-001-03-0; hydroxymethyl-(hydroxymethyl-methyl-dioxo-[ ]yl)-methyl-[ ]dione; [10b,10'b(11H,11'H)-Bi-3,11a-epidithio-11aH-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole]-1,1',4,4'-tetrone, 2,2',3,3',5a,5'a,6,6'-octahydro-3,3'-bis(hydroxymethyl)-2,2'-dime
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| Activity | IC50 = 800 nM | |||
| External Link | ||||
References